Cover Image

Apremilast and NB-UVB combination therapy in moderate-to-severe plaque type psoriasis

Saved in:

Bibliographic Details
Main Authors:	O. Yu Olisova (Author), D.A. Svistunova (Author), E.M. Anpilogova (Author)
Format:	Book
Published:	Wolters Kluwer, 2020-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
by: Gisondi P, et al.
Published: (2016)

Narrowband Ultraviolet B (NB-UVB) Phototherapy in Psoriasis: A Retrospective Study
by: Faida Ufaira Prameswari, et al.
Published: (2022)

A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
by: Divyanshu Srivastava, et al.
Published: (2023)

Doxycycline Combined with NB-UVB Phototherapy for Acquired Reactive Perforating Collagenosis
by: Gao L, et al.
Published: (2020)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
by: Gao JC, et al.
Published: (2022)

Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy
by: Li X, et al.
Published: (2023)

Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective
by: Marzieh Zargaran, et al.
Published: (2021)

Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
by: O. Yu. Olisova, et al.
Published: (2019)

Real-world insight on apremilast therapy in patients with plaque psoriasis: Indian experience
by: Abhishek De, et al.
Published: (2020)

Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis
by: A. A. Kubanov, et al.
Published: (2019)

High-Throughput RNA Sequencing Reveals the Effect of NB-UVB Phototherapy on Major Inflammatory Molecules of Lesional Psoriasis
by: Vacharanukrauh P, et al.
Published: (2021)

Real-world efficacy and safety of apremilast monotherapy in the management of moderate-to-severe Psoriasis
by: Bela J Shah, et al.
Published: (2020)

Comparison of Psoriasis Area and Severity Index (PASI) Scores in Patients Treated with Oral Methotrexate and A Combination of Oral Methotrexate and Narrow Band-Ultraviolet B (NB-UVB) Phototherapy
by: Ervina Rosmarwati, et al.
Published: (2022)

Efficacy of tincture of compound Flos Sophorae and Fructus Psoraleae in combination with NB-UVB for stable sporadic vitiligo
by: Chun-lei HAN, et al.
Published: (2019)

Histopathologic evaluation of parapsoriasis from the perspective of NB-UVB/PUVA therapy on the outcome and recurrence of the disease
by: Tumay Ozgur, et al.
Published: (2021)

Cost per response analysis of deucravacitinib versus apremilast and first-line biologics among patients with moderate to severe plaque psoriasis in the United States
by: Sang Hee Park, et al.
Published: (2024)

Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis
by: April W. Armstrong, et al.
Published: (2024)

Successful treatment of cutaneous B-cell pseudolymphoma with photodynamic therapy
by: O. Yu Olisova, et al.
Published: (2020)

Characteristics and decreased VASI of vitiligo patients with NB-UVB phototherapy in Yogyakarta, Indonesia
by: Nabila Kirtti Pradipta, et al.
Published: (2023)

Refractory nummular eczema in child successfully treated with NB‐UVB and topical delgocitinib
by: Ichiro Kurokawa, et al.
Published: (2022)

Systemic treatment of psoriasis: from methotrexate to biologics
by: Olga Yu. Olisova, et al.
Published: (2020)

Clindamycin/benzoyl peroxid gel in mild-to-moderate acne
by: Olga Yu. Olisova, et al.
Published: (2023)

Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis
by: Kaplan DL, et al.
Published: (2020)

Clinico-Epidemiological Profile of Vitiligo Patients Receiving Narrowband Ultraviolet-B (NB-UVB) Treatment
by: Anasya Putri Ramadhina, et al.
Published: (2023)

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
by: Giunta A, et al.
Published: (2017)

Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents
by: Audrey Melin, et al.
Published: (2021)

Clinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
by: Light JG, et al.
Published: (2021)

Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Ren V, et al.
Published: (2013)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Sekhon S, et al.
Published: (2017)

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
by: Jin JQ, et al.
Published: (2023)

Apremilast Use for Moderate-to-Severe Atopic Dermatitis in Pediatric Patients
by: Rachael C. Saporito, et al.
Published: (2016)

Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy
by: Roman M, et al.
Published: (2017)

Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016)

Apremilast for lithium-associated psoriasis
by: Joohyung Youh, et al.
Published: (2022)

Treatment of erythrodermic psoriasis with apremilast
by: Olivia A. Gioe, MD, et al.
Published: (2021)

Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials
by: Alexander Egeberg, et al.
Published: (2024)

Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting
by: Alessio Gambardella, et al.
Published: (2023)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
by: Martina Burlando, et al.
Published: (2021)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
by: Ruggiero A, et al.
Published: (2023)